FUTURE OF HEALTHCARE, MEDICAL DEVICES
Greenway Health | December 29, 2022
Greenway Health, a leading provider of health information technology services, has recently launched the Greenway Engagement Model (GEM), a new client engagement program.
Through intentional interaction and strategic support, the program is intended to strengthen Greenway's trusted advisor relationship with clients and support a more successful healthcare technology journey for Greenway clients.
The GEM program offers a dedicated client support team, which develops a client feedback program focused on improving the user experience and patient outcomes, reducing clinician burnout, and advancing technology that best serves healthcare providers. The program is focused on creating an upgraded experience not yet seen in the healthcare IT industry.
Clients will benefit from value-added services like clinical and revenue cycle assessments with optimization recommendations, benchmarking, and tracking of client-specific KPIs (key performance indicators) to help their practice grow. This is one of the most integrated customer engagement programs ever launched by Greenway Health. In order to provide a top-notch experience, each client will also receive simplified engagement from the Greenway team, including executive or senior leader sponsorship.
The company firmly believes in bringing trust, loyalty, and knowledge to its customers, which necessitates a tailored engagement model that creates a user-friendly platform for the customers to share their experiences and receive hands-on support. GEM's overarching objective is to make sure that its clients enjoy fruitful cooperation with Greenway in the area of healthcare technology so that they can return to doing what they do best—serving patients.
About Greenway Health
Greenway Health provides cutting-edge technology, first-rate services, and strategic alliances with the aim of assisting clients in achieving success. The clinical, financial, and technology experts employed at Greenway are committed to creating cutting-edge solutions that maintain people's well-being. As a consequence of Greenway's partnerships with businesses and innovative service providers across numerous industries, its solutions have a daily impact on millions of lives.
Read More
HEALTH TECHNOLOGY, DIGITAL HEALTHCARE
KARL STORZ | December 21, 2022
KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas.
Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models.
TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures.
Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% and reduce errors by 63% especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy.
Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense.
“KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution. The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.”
Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc
“Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.”
KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas.
Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models.
TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures.
Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% (44 of 69 studies) and reduce errors by 63% (28 of 45 studies), especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy.
Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense.
“KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution,” said Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc. “The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.”
“Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.”
About Vizient
Vizient represents a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers and represents approximately $130 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.
About KARL STORZ
KARL STORZ Endoscopy-America, Inc. is an innovative leader in endoscopic technology and imaging solutions across virtually all surgical specialties. KARL STORZ provides solutions that facilitate operational and workflow efficiencies across various sites of care, so healthcare providers can deliver optimal patient care in the most cost-effective manner. The group is an affiliate of KARL STORZ SE & Co. KG, an international leader and family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness.
Read More
FUTURE OF HEALTHCARE, DIGITAL HEALTHCARE
Medisafe | January 05, 2023
Medisafe, a digital therapeutics firm focused on medication engagement, recently introduced SaMD technology. This announcement comes months after receiving ISO 13485:2016 accreditation for medical devices and ISO 27001:2013 certification for pharmaceutical and digital health platforms. These international registrations demonstrate Medisafe's clinical management and patient engagement leadership.
With the market for disease management software growing, Medisafe's development shows that the company is committed to following the law, going above and beyond what is expected, and being at the forefront of SaMD development.
The achievements made by Medisafe in the past year to better serve patients, doctors, and pharma partners have earned the company a great deal of pride. Medisafe remarked that the most recent announcement of registering as a SaMD is not only a crucial step in the company's development, but it is also essential that it anticipate and address changing customer and industry needs, both regulated and unregulated, as leaders and innovators in digital therapeutics.
Medisafe continues to focus on non-regulated business-building solutions that exceed the needs of pharma, HUBs, providers, and patients.
Through an interoperable, individualized, and patient-centric approach to digital patient connectivity, Medisafe's end-to-end Care Connector platform enables organizations to effectively engage with patients throughout the medication journey, supporting pharma's vision for a more digitally enhanced future. More than 10 million registrants utilize and rely on Medisafe's platform and digital drug companion to manage their medications, validating the value it brings to patients.
Meanwhile, Medisafe will attend the 41st Annual J.P. Morgan Healthcare Conference, which will take place on January 9–12, 2023, in San Francisco, CA, USA.
About Medisafe
Medisafe® is a premier personalized medication management platform that connects users to their families (and soon, their doctors) for support, encouragement, and expertise to provide customized notifications for visits and refills, prescription updates, personalized health advice, and discounts. It monitors blood pressure and glucose to show the benefits of taking drugs as prescribed. The company improves patient happiness and care by preventing inaccurate or missed dosages.
Read More